⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 5, 2019Advances in TherapyOpen Access

Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Astellas Pharma Inc.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Akizawa et al. (2019) studied this question.

synapsesocial.com/papers/69d774e3b843b2be9948fd9d https://doi.org/10.1007/s12325-019-00943-4

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1How the Target Hemoglobin of Renal Anemia Should Be?RCT · 2015 · 416 citations
2Roxadustat (FG-4592)Original Research · 2015 · 251 citations
3The FDA's Perspective on the Risk for Rapid Rise in Hemoglobin in Treating CKD AnemiaRisk Assessment · 2010 · 15 citations
4Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease PatientsReview · 2017 · 4,818 citations
5Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in ChinaRCT · 2017 · 201 citations